Arrowhead Pharmaceuticals could notch more gains as the biotechnology firm prepares to release data tied to clinical trials ...

With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 7, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 ...

A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...

If CRISPR stays active too long, it could cut unintended parts of the genome. To reduce this risk, the researchers designed a self-inactivating CRISPR system. This means that CRISPR edits the gene and ...

Featured In Biomedwire Editorial Highlighting Biotech's Shift Toward Science-Driven Asset Valuation. Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage ...

A Martin-Gatton College of Agriculture, Food and Environment researcher is leading a new project that could help farmers ...

Graph theory and computational modeling reveal that neural network architecture biases the male Caenorhabditis elegans brain toward prioritized sexual behaviors.

Internationally-renowned scientist Professor Greg Hannon, who led the Cancer Research UK (CRUK) Cambridge Institute for more ...